Literature DB >> 3319565

Possible neurologic effects of aspartame, a widely used food additive.

T J Maher1, R J Wurtman.   

Abstract

The artificial sweetener aspartame (L-aspartyl-L-phenylalanyl-methyl ester), is consumed, primarily in beverages, by a very large number of Americans, causing significant elevations in plasma and, probably, brain phenylalanine levels. Anecdotal reports suggest that some people suffer neurologic or behavioral reactions in association with aspartame consumption. Since phenylalanine can be neurotoxic and can affect the synthesis of inhibitory monoamine neurotransmitters, the phenylalanine in aspartame could conceiveably mediate neurologic effects. If mice are given aspartame in doses that elevate plasma phenylalanine levels more than those of tyrosine (which probably occurs after any aspartame dose in humans), the frequency of seizures following the administration of an epileptogenic drug, pentylenetetrazole, is enhanced. This effect is simulated by equimolar phenylalanine and blocked by concurrent administration of valine, which blocks phenylalanine's entry into the brain. Aspartame also potentiates the induction of seizures by inhaled fluorothyl or by electroconvulsive shock. Perhaps regulations concerning the sale of food additives should be modified to require the reporting of adverse reactions and the continuing conduct of mandated safety research.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3319565      PMCID: PMC1474447          DOI: 10.1289/ehp.877553

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  19 in total

1.  Interaction of aspartame and carbohydrates in an eating-disordered patient.

Authors:  J M Ferguson
Journal:  Am J Psychiatry       Date:  1985-02       Impact factor: 18.112

2.  Diurnal variations in plasma concentrations of basic and neutral amino acids and in red cell concentrations of aspartate and glutamate: effects of dietary protein intake.

Authors:  T J Maher; B S Glaeser; R J Wurtman
Journal:  Am J Clin Nutr       Date:  1984-05       Impact factor: 7.045

3.  Strategies for assessing the effects of food additives on the brain and behavior.

Authors:  R J Wurtman; T J Maher
Journal:  Fundam Appl Toxicol       Date:  1984-06

4.  Neutral amino acids in the brain: changes in response to food ingestion.

Authors:  J D Fernstrom; D V Faller
Journal:  J Neurochem       Date:  1978-06       Impact factor: 5.372

5.  Effects of phenylalanine on the release of endogenous dopamine from rat striatal slices.

Authors:  J D Milner; K Irie; R J Wurtman
Journal:  J Neurochem       Date:  1986-11       Impact factor: 5.372

6.  Diurnal variations in plasma concentrations of tryptophan, tryosine, and other neutral amino acids: effect of dietary protein intake.

Authors:  J D Fernstrom; R J Wurtman; B Hammarstrom-Wiklund; W M Rand; H N Munro; C S Davidson
Journal:  Am J Clin Nutr       Date:  1979-09       Impact factor: 7.045

7.  Comparative metabolism of aspartame in experimental animals and humans.

Authors:  R E Ranney; J A Oppermann; E Muldoon; F G McMahon
Journal:  J Toxicol Environ Health       Date:  1976-11

8.  Effects of untreated maternal phenylketonuria and hyperphenylalaninemia on the fetus.

Authors:  H L Levy; S E Waisbren
Journal:  N Engl J Med       Date:  1983-11-24       Impact factor: 91.245

9.  Effect of an abuse dose of aspartame upon plasma and erythrocyte levels of amino acids in phenylketonuric heterozygous and normal adults.

Authors:  L D Stegink; L J Filer; G L Baker; J E McDonnell
Journal:  J Nutr       Date:  1980-11       Impact factor: 4.798

10.  Acute effects of aspartame on large neutral amino acids and monoamines in rat brain.

Authors:  J D Fernstrom; M H Fernstrom; M A Gillis
Journal:  Life Sci       Date:  1983-04-04       Impact factor: 5.037

View more
  12 in total

1.  Prooxidative effects of aspartame on antioxidant defense status in erythrocytes of rats.

Authors:  Marko D Prokic; Milica G Paunovic; Milos M Matic; Natasa Z Djordjevic; Branka I Ognjanovic; Andras S Stajn; Zorica S Saicic
Journal:  J Biosci       Date:  2014-12       Impact factor: 1.826

2.  Neuropsychological and biochemical investigations in heterozygotes for phenylketonuria during ingestion of high dose aspartame (a sweetener containing phenylalanine).

Authors:  F Trefz; L de Sonneville; P Matthis; C Benninger; B Lanz-Englert; H Bickel
Journal:  Hum Genet       Date:  1994-04       Impact factor: 4.132

3.  Aspartame and seizures.

Authors:  P C Jobe; J W Dailey
Journal:  Amino Acids       Date:  1993-10       Impact factor: 3.520

4.  Effect of chronic exposure to aspartame on oxidative stress in the brain of albino rats.

Authors:  Ashok Iyyaswamy; Sheeladevi Rathinasamy
Journal:  J Biosci       Date:  2012-09       Impact factor: 1.826

5.  ToxiM: A Toxicity Prediction Tool for Small Molecules Developed Using Machine Learning and Chemoinformatics Approaches.

Authors:  Ashok K Sharma; Gopal N Srivastava; Ankita Roy; Vineet K Sharma
Journal:  Front Pharmacol       Date:  2017-11-30       Impact factor: 5.810

Review 6.  Pharmacological effects of phenylalanine on seizure susceptibility: an overview.

Authors:  P Y Sze
Journal:  Neurochem Res       Date:  1989-02       Impact factor: 3.996

7.  Use of acceptable daily intake (ADI) as a health-based benchmark in nutrition research studies that consider the safety of low-calorie sweeteners (LCS): a systematic map.

Authors:  Deepa Handu; Samuel M Cohen; Njwen Anyangwe; Seneca E Fitch; Lauren E Payne; Jennifer L G van de Ligt; Candace Doepker; Daniele Wikoff
Journal:  BMC Public Health       Date:  2021-05-20       Impact factor: 3.295

8.  Nonnutritive, low caloric substitutes for food sugars: clinical implications for addressing the incidence of dental caries and overweight/obesity.

Authors:  Michael W Roberts; J Timothy Wright
Journal:  Int J Dent       Date:  2012-02-22

9.  Acute effect of aspartame-induced oxidative stress in Wistar albino rat brain.

Authors:  Iyaswamy Ashok; Rathinasamy Sheeladevi; Dapkupar Wankhar
Journal:  J Biomed Res       Date:  2014-01-12

10.  Prediabetic changes in gene expression induced by aspartame and monosodium glutamate in Trans fat-fed C57Bl/6 J mice.

Authors:  Kate S Collison; Nadine J Makhoul; Marya Z Zaidi; Angela Inglis; Bernard L Andres; Rosario Ubungen; Soad Saleh; Futwan A Al-Mohanna
Journal:  Nutr Metab (Lond)       Date:  2013-06-19       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.